Innovative ETFs Content Hub Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook By Max ChenMarch 6, 2019
Innovative ETFs Content Hub A Specialty Biotech ETF Strengthens on Optimism Over CRISPR Advancements By Max ChenMarch 1, 2019
Innovative ETFs Content Hub Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results By Max ChenFebruary 28, 2019
Innovative ETFs Content Hub Specialized Biotech ETF Rallies on MacroGenics Positive Trial Results By Max ChenFebruary 6, 2019
Core Equity Content Hub Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook By Max ChenJanuary 23, 2019
Equity ETFs Biotech ETFs Pop as Bristol-Myers Squibb Set to Acquire Celgene By Max ChenJanuary 3, 2019
